Industry News
-
Genespire Presents Positive Preclinical Dosing Data for In Vivo Gene Therapy for Methylmalonic Acidemia
May 14 2025 -
Latus Bio Announces Novel AAV Capsid AAV-Ep+ Demonstrates Robust Brain Transduction and Therapeutic Protein Expression in Preclinical Studies
May 14 2025 -
Rgenta’s RSwitch Platform Reported to Regulate Gene Therapy Transgene Expression
May 13 2025 -
REGENXBIO Announces FDA Acceptance and Priority Review of BLA for RGX-121 Gene Therapy in Hunter Syndrome
May 13 2025 -
Sarepta Therapeutics’ Delandistrogene Moxeparvovec Receives Conditional Approval in Japan for Younger Duchenne Patients
May 13 2025 -
Beam Therapeutics Receives FDA RMAT Designation for BEAM-302 Base Editing Therapy for Alpha-1 Antitrypsin Deficiency
May 12 2025 -
Capsida Biotherapeutics Receives FDA Clearance for IND Application for CAP-002 Gene Therapy for STXBP1-DEE
May 12 2025 -
Genascence Announces Positive 12-Month Safety and Biomarker Data for GNSC-001 Gene Therapy in Knee Osteoarthritis Trial
May 12 2025 -
Stylus Medicine Launches with $85 Million to Tackle Major Cell & Gene Therapy Challenges with Novel Gene Editing Technology
May 12 2025